Brief: Century Therapeutics To Reduce Headcount By 51%
07/07/2025 22:55
July 7 (Reuters) - Century Therapeutics Inc IPSC.O: CENTURY THERAPEUTICS INC - TO REDUCE HEADCOUNT BY 51% - SEC FILING CENTURY THERAPEUTICS INC - DEPARTURE OF CFO MORGAN CONN AND CDO ADRIENNE FARID - SEC FILING CENTURY THERAPEUTICS INC - ESTIMATES $3.7 MILLION IN SEVERANCE COSTS - SEC FILING CENTURY THERAPEUTICS INC - DOUGLAS CARR TO SERVE AS INTERIM PRINCIPAL FINANCIAL OFFICER - SEC FILING CENTURY THERAPEUTICS INC: ESTIMATES WORKFORCE REDUCTION TO BE SUBSTANTIALLY COMPLETED BY Q3 2025 Further company coverage: IPSC.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Century Therapeutics
See all newsCentury Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Century Therapeutics Q2 net loss misses estimates on lease termination loss
Brief: Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 Million
Century Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Century Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview